SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000882104-20-000113
Filing Date
2020-08-06
Accepted
2020-08-06 16:10:25
Documents
2
Effectiveness Date
2020-08-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A pdli-20200806defa14adoc1.htm DEFA14A 481900
2 LOGO pdllogoa351.jpg GRAPHIC 123123
  Complete submission text file 0000882104-20-000113.txt   652450
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 201081689
SIC: 2836 Biological Products, (No Diagnostic Substances)